Word

TAILOR BIO

Status

Pending

Status Code

630

Status Date

Tuesday, May 14, 2024

Serial Number

98549945

Mark Type

4

Filing Date

Tuesday, May 14, 2024

Trademark Owner History

TAILOR BIO LTD

Classifications

41 Publication of books; publication of journals; publication of electronic books and journals online; publication of material that can be accessed from databases or from the Internet; publication of the results of clinical trials; publication of the results of clinical trials for pharmaceutical preparations

9 Downloadable software; application software; computer software; bioinformatics software; computer software platforms; artificial intelligence software; artificial intelligence software platforms; artificial intelligence software for searching, tracking, exploration, and analysis of data for use in the field of healthcare; artificial intelligence software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines for cancers with chromosomal abnormalities; Computer hardware and software for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; Scientific apparatus and instruments; scientific specimens for laboratory use

5 Pharmaceuticals; pharmaceutical drugs; pharmaceutical preparations; pharmaceutical preparations for the treatment of cancers; pharmaceutical preparations for the treatment of cancers with chromosomal abnormalities; pharmaceutical preparations for the treatment of cancers with chromosomal instabilities; pharmaceutical preparations acting on cancers; pharmaceutical preparations acting on cancers with chromosomal abnormalities; pharmaceutical preparations acting on cancers with chromosomal instabilities; medicine; medicines for human purposes; medicine for the treatment of cancers with chromosomal abnormalities; medicine for the treatment of cancers with chromosomal instabilities; chemicals for pharmaceutical use; chemical reagents for medical use; chemical preparations for medical purposes; drugs for medical purposes

35 Database management; Database management and reporting services; Business information services; Business consulting services; Business consulting services in the field of drug discovery; Business consulting services in the field of biomarker discovery; Business consulting services in the field of genomics; Business consulting in the field of chromosomal abnormalities; Market intelligence services; Data processing; Data processing in the field of drug discovery; Data processing in the field of medical diagnosis; Data processing in the field of biomarker discovery; Data processing in the field of genomics; Data processing in the field of bioinformatics; Data processing in the field of chromosomal abnormalities; Data processing in the field of chromosomal instabilities; Information, advisory and consultancy services in relation to all of the aforesaid

1 Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations; Kits containing reagents and a protocol for use thereof for non-medical purposes; Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics; Kits comprising nucleotides, reagents, enzyme substrates, buffers, chemical preparations, or biological preparations for scientific and research use including in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology

44 Healthcare services; healthcare information, advisory and consultancy services for cancers with chromosomal abnormalities; healthcare information, advisory and consultancy services for cancers with chromosomal instabilities; medical services; medical information, advisory and consultancy services for cancers with chromosomal abnormalities; Medical testing for diagnostic or treatment purposes; pharmaceutical services; pharmaceutical information, advisory and consultancy services for cancers with chromosomal abnormalities; medical testing for diagnostic or treatment purposes; pharmaceutical services; pharmaceutical information, advisory and consultancy services for cancers with chromosomal instabilities; advisory and collation of information in the healthcare sector; providing medical information in the healthcare sector; providing medical information concerning pharmaceuticals and the research and development of pharmaceuticals for cancers with chromosomal abnormalities; advisory and collation of information in the healthcare sector; providing medical information in the healthcare sector; providing medical information concerning pharmaceuticals and the research and development of pharmaceuticals for cancers with chromosomal instabilities; health consultancy, medical treatment services, provision of personalised medicine in the field of rare diseases, advisory services relating to rare diseases; advisory services relating to treatment of rare diseases; medical health assessment services; advisory services relating to medical instruments; therapy services; medical and health services relating to DNA, genetics and genetic testing; genetic testing for medical purposes; Providing cancers screening services

42 Compilation of data for use in scientific research; Data analysis; Data analysis in the field of drug discovery; Data analysis in the field of medical diagnosis; Data analysis in the field of biomarker discovery; Data analysis in the field of genomics; Data analysis in the field of bioinformatics; Data analysis in the field of chromosomal abnormalities; Data analysis in the field of chromosomal instabilities; Scientific and technological services; design and development of computer software; providing online non-downloadable computer software; providing online non-downloadable computer software for searching, tracking, exploration and analysis of data for use in the field of healthcare; providing online non-downloadable computer software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; Platform as a Service (PaaS); Platform as a Service (PaaS), namely, providing computational methods and software for searching, tracking, exploration and analysis of data for use in the field of healthcare; Platform as a Service (PaaS), namely, providing computational methods and software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; Software as a Service (SaaS); Software as a Service (SaaS), namely, providing computational methods and software for searching, tracking, exploration and analysis of data for use in the field of healthcare; Software as a Service (SaaS), namely, providing artificial intelligence software for searching, tracking, exploration and analysis of data for use in the field of healthcare relating to chromosomal abnormalities; Software as a Service (SaaS), namely, providing artificial intelligence software for searching, tracking, exploration and analysis of data for use in the field of healthcare relating to chromosomal instabilities; Software as a Service (SaaS), namely, providing computational methods and software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; hosting platforms on the Internet; hosting of digital content online; hosting of digital content, namely, drug discovery and development research; hosting of digital content, namely, chromosomal abnormality research; hosting of digital content, namely, chromosomal instability research; Medical and scientific research in the field of drug target discovery for development of pan-cancer precision therapies; medical and scientific research in the field of drug target discovery for development of pan-cancer precision therapies using chromosomal abnormalities; medical and scientific research in the field of drug target discovery for development of pan-cancer precision therapies; medical and scientific research in the field of drug target discovery for development of pancancer precision therapies using chromosomal instabilities; writing of computer programs for medical applications; writing of computer programs for biotechnological applications; writing of computer programs for drug discovery applications; writing of computer programs for diagnostic applications; writing of data processing programs; scientific and medical research and development services; scientific research conducted using databases and the Internet; medical research services; pharmaceutical research and development services; pharmaceutical product evaluation; research and development of pharmaceutical preparations and medicines; research and development of pharmaceuticals for the treatment of cancers; drug discovery services; services for assessing the efficiency of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of pharmaceutical research and development; information technology consulting services for the pharmaceutical and healthcare industries; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information, advisory and consultancy services regarding information technology services for the pharmaceutical and healthcare industries, all of the aforesaid services also provided online via a database or the Internet; providing information, advisory and consultancy services regarding research and development of pharmaceutical preparations and medicines, all of the aforesaid services also provided online via a database or the Internet; Scientific research; clinical research; clinical trials; biological research; biological research, clinical research and medical research; providing information on clinical studies via an interactive website, research in the field of gene therapy; genetic engineering services; genetic research; scientific research in the field of genetics and genetic engineering, biomarker research, drug discovery and development; technical consultancy in relation to research services relating to foods and dietary supplements; research relating to medicine

Trademark Events

May 14, 2024

New Application Entered

May 14, 2024

New Application Office Supplied Data Entered